Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-09-022923
Filing Date
2009-04-27
Accepted
2009-04-27 17:55:53
Documents
2
Period of Report
2009-04-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4214
2 POA DOCUMENT poa.txt EX-24.4_284082 2785
  Complete submission text file 0001209191-09-022923.txt   8681
Mailing Address C/O OXIGENE, INC. 230 THIRD AVENUE WALTHAM MA 02451
Business Address
Chin Richard (Reporting) CIK: 0001337252 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33958 | Film No.: 09773568

Mailing Address 60 PRESCOTT STREET WORCESTER MA 01605
Business Address 60 PRESCOTT STREET WORCESTER MA 01605 508-767-3861
RXI PHARMACEUTICALS CORP (Issuer) CIK: 0001390478 (see all company filings)

EIN.: 000000000
SIC: 2834 Pharmaceutical Preparations